NCT04595474View on ClinicalTrials.gov

Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

Active, not recruitingOBSERVATIONAL
Enrollment

533

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

August 19, 2022

Study Completion Date

December 30, 2025

Conditions
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisFibrosis, LiverType 1 DiabetesCirrhosis, Liver
Interventions
DEVICE

Transient Elastography

Transient elastography is a noninvasive imaging modality used to assess NAFLD and advanced fibrosis

Trial Locations (1)

02215

Joslin Diabetes Center, Boston

All Listed Sponsors
lead

Joslin Diabetes Center

OTHER